Categories
Zydus Lifesciences Limited — Updates, 06-05-2026: Press Release
06-05-2026 · 11:03 am
Zydus Lifesciences' Ahmedabad Biologics Injectable plant concluded a USFDA GMP surveillance inspection, resulting in seven observations. There were no data integrity related findings. The company will expeditiously address the issues.
No comments yet. Be the first to comment!